You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 21, 2025

Details for Patent: RE34990


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE34990
Title: Oral therapeutic system having systemic action
Abstract:The invention relates to a therapeutic system for peroral administration and having systemic action, which system is in the form of a coated and/or laminated mono-compartment system for administering carbamazepine. The therapeutic system comprises (a) a wall made of a material which is permeable to water and impermeable to the components of the drug-containing core, (b) a core containing finely particulate carbamazepine as drug and, as auxiliaries, a protective colloid that inhibits the crystal growth of carbamazepine in the presence of water, a swellable hydrophilic polymer and, optionally, a water-soluble compound for inducing osmosis and/or further pharmaceutically acceptable excipients, and (c) a passageway through the wall (a) for delivering the core components to the environmental body fluid. The therapeutic system can be used as an anticonvulsive for the treatment of convulsive states, especially epileptic states.
Inventor(s): Khanna; Satish C. (Bottmingen, CH), Ruttimann; Theresa (Basel, CH)
Assignee: Ciba-Geigy Corporation (Ardsley, NY)
Application Number:08/133,814
Patent Claim Types:
see list of patent claims
Compound; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of U.S. Patent RE34990: A Comprehensive Guide

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will provide a detailed analysis of the scope and claims of U.S. Patent RE34990, using relevant legal and technical frameworks.

Understanding Patent Scope

Patent scope is a critical aspect of patent law, determining the breadth and limits of what is protected by a patent. It is often measured using metrics such as independent claim length and independent claim count[5].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the invention and the scope of protection. They must be clear, concise, and supported by the patent's description. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, which can be used to analyze patent scope[3].

U.S. Patent RE34990: Background

To analyze U.S. Patent RE34990, one must first understand its background, including the invention it covers, the filing and grant history, and any reexaminations or legal challenges it may have faced.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims in a patent. This is a critical step in determining the scope of the patent. The claims of RE34990 must be analyzed in the context of the patent's specification and any relevant prior art[4].

Independent Claims

Independent claims stand alone and do not depend on other claims. They define the broadest scope of the invention. Analyzing the independent claims of RE34990 will help in understanding the core of the invention.

Dependent Claims

Dependent claims build upon independent claims and narrow down the scope. They often add specific limitations or features to the invention. The dependent claims of RE34990 will provide additional details about the invention's scope.

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This doctrine is particularly relevant when patents have been granted Patent Term Adjustments (PTA) or Patent Term Extensions (PTE)[1].

Impact on RE34990

If RE34990 has undergone reexamination or has been subject to ODP analysis, it is crucial to understand how these processes have affected its claims and scope. The Federal Circuit's decision in cases like In re Cellect provides guidance on how ODP and terminal disclaimers impact patent term adjustments[1].

Patent Term Adjustments and Extensions

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE) can extend the life of a patent. However, these adjustments must be considered in the context of ODP to ensure that the patent does not unfairly extend its term.

PTA and PTE in RE34990

If RE34990 has been granted PTA or PTE, understanding how these adjustments affect its expiration date is essential. The Board's findings in In re Cellect indicate that ODP analysis should be based on the adjusted expiration date of the patent[1].

Legal and Regulatory Framework

The legal framework governing patents in the U.S. is complex and involves various statutes and case laws. The USPTO and the Federal Circuit play significant roles in interpreting these laws.

Statutory Language and Case Law

The statutory language of 35 U.S.C. § 154 and relevant case law, such as Merck & Co. v. Hi-Tech Pharmacal Co., are crucial in determining the scope and claims of RE34990. These sources provide guidance on issues like terminal disclaimers and patent term extensions[1].

Practical Considerations for Stakeholders

For inventors, businesses, and legal professionals, understanding the scope and claims of RE34990 is vital for several reasons:

Licensing and Litigation

The scope of the patent determines what can be licensed and what may be subject to litigation. Broader claims may increase licensing and litigation costs, while narrower claims may reduce these risks[5].

Innovation Incentives

The clarity and validity of patent claims can influence innovation incentives. Patents with clear and valid claims are more likely to encourage innovation by providing clear boundaries of protection[5].

Tools and Resources for Patent Analysis

Several tools and resources are available for analyzing patents:

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching and analyzing patents. It provides enhanced access to prior art and other relevant information[4].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, which can be useful in understanding the global patent landscape[4].

Patent Claims Research Dataset

This dataset, provided by the USPTO, contains detailed information on claims from U.S. patents and can be used to analyze patent scope and trends[3].

Case Studies and Expert Insights

Expert insights and case studies can provide valuable context for understanding the scope and claims of RE34990.

Expert Opinions

Experts in patent law, such as those involved in the ACUS study on small claims patent courts, can offer insights into the practical implications of patent scope and claims[2].

Relevant Case Law

Cases like In re Cellect and Merck & Co. v. Hi-Tech Pharmacal Co. provide legal precedents that can help in interpreting the scope and claims of RE34990[1].

Challenges and Controversies

Analyzing the scope and claims of RE34990 may also involve addressing challenges and controversies, such as those related to ODP and patent term adjustments.

ODP Analysis

The ODP analysis in cases like In re Cellect highlights the complexities involved in determining whether a patent is unpatentable due to ODP. This analysis is crucial for maintaining the integrity of the patent system[1].

Public Comments and Stakeholder Input

Public comments and stakeholder input, as seen in the ACUS study, can provide a broader perspective on the issues surrounding patent scope and claims[2].

Key Takeaways

  • Patent Scope: Understanding the scope of a patent is crucial and can be measured using metrics like independent claim length and count.
  • Claim Construction: Claim construction is essential for determining the scope of protection.
  • ODP and PTA/PTE: ODP analysis and patent term adjustments/extensions can significantly impact the scope and term of a patent.
  • Legal Framework: Statutory language and case law provide the foundation for interpreting patent claims and scope.
  • Practical Considerations: Clear and valid claims are vital for licensing, litigation, and innovation incentives.

FAQs

Q: What is the significance of independent claims in a patent?

Independent claims define the broadest scope of the invention and are crucial for understanding the core of the patent.

Q: How does ODP impact patent term adjustments?

ODP analysis must be based on the adjusted expiration date of the patent, ensuring that the patent term is not unfairly extended[1].

Q: What tools are available for analyzing patent claims?

Tools like the USPTO's Patent Public Search, Global Dossier, and the Patent Claims Research Dataset are invaluable for analyzing patent claims and scope[3][4].

Q: Why is claim construction important?

Claim construction is essential for determining the scope of protection and ensuring that the patent claims are clear and valid.

Q: How do patent term extensions and adjustments affect the scope of a patent?

Patent term extensions and adjustments can extend the life of a patent but must be considered in the context of ODP to avoid unfair extensions[1].

Sources

  1. In re Cellect, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Claims Research Dataset, United States Patent and Trademark Office.
  4. Search for patents, United States Patent and Trademark Office.
  5. Patent Claims and Patent Scope, SSRN, September 29, 2016.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE34990

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent RE34990

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 597403 ⤷  Try for Free
Australia 7661787 ⤷  Try for Free
Austria 397344 ⤷  Try for Free
Austria A199387 ⤷  Try for Free
Belgium 1000235 ⤷  Try for Free
Canada 1302267 ⤷  Try for Free
Switzerland 668187 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.